From: The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
KRAS codon 12 | ||
---|---|---|
c.34GÂ >Â A | Gly12Ser | 16 |
c.34GÂ >Â C | Gly12Arg | 2 |
c.34GÂ >Â T | Gly12Cys | 31 |
c.35GÂ >Â A | Gly12Asp | 148 |
c.35GÂ >Â T | Gly12Asp | 1 |
c.35GÂ >Â T | Gly12Val | 88 |
c.38GÂ >Â A | Gly12Asp | 5 |
c.35GÂ >Â C | Gly12Ala | 11 |
KRAS codon 13 | ||
c.35GÂ >Â A | Gly13Asp | 1 |
c.38GÂ >Â A | Gly13Asp | 97 |
c.37GÂ >Â T | Gly13Cys | 2 |
c.36GÂ >Â T | Gly13Val | 2 |
c.38_39 GCÂ >Â TT | Gly13Val | 1 |
KRAS codon 14 | ||
c.40GÂ >Â A | Val14lle | 1 |
KRAS codon 30 | ||
c.90CÂ >Â T | Asp30Asp | 1 |